Home › NDC Lookup › RxCUI directory › RxCUI 2056748

Latanoprost 0.05 MG/ML Ophthalmic Suspension [Xelpros] — RxCUI 2056748

RxNorm drug concept · Semantic branded drug
RxCUI 2056748 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2056748
Official nameLatanoprost 0.05 MG/ML Ophthalmic Suspension [Xelpros]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asXelpros 0.05 MG/ML Ophthalmic Emulsion; Xelprox 0.005 % Ophthalmic Emulsion; Xelpros 0.05 MG/ML Ophthalmic Suspension
FDA products mapped1
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Latanoprost Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The evening timing is the recommended dosing schedule from clinical studies, and it's important to stick with it consistently. Using it at the same time every evening helps keep yo...
  • Why do I have to use this at night? Can I use it in the morning instead?
  • Yes, this is a real and well-documented effect of latanoprost. Over months to years, the iris (colored part of your eye) can gradually become more brown due to increased pigment. T...
  • Will my eye color really change? Is that permanent?
📖 Read our full Latanoprost Ophthalmic guide →

🕸️ Concept Web — How Latanoprost 0.05 MG/ML Ophthalmic Suspension [Xe... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Latanoprost 0.05 MG/ML Ophthalmic Suspension [Xelpros] RxCUI 2056748

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Latanoprost 43611
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Xelpros 2056744
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Latanoprost Ophthalmic Suspension 2056742
    • Latanoprost Ophthalmic Product 1162555
    • Latanoprost Ophthalmic Suspension [Xelpros] 2056746
    • Xelpros Ophthalmic Product 2056747
    • Ophthalmic Suspension 316964
    • Ophthalmic Product 1151135
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Latanoprost 0.05 MG/ML [Xelpros] SBDC · 2056745
  • Latanoprost Ophthalmic Suspension [Xelpros] SBDF · 2056746
  • Xelpros Ophthalmic Product SBDG · 2056747
  • Xelpros BN · 2056744

📦 FDA Products & Package NDCs

1 product · 4 package NDCs
4 package NDCs map to RxCUI 2056748 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
47335-0317-90 1 BOTTLE, DROPPER in 1 BOX (47335-317-90) / 2.5 mL in 1 BOT... XELPROS Sun Pharmaceutical Industries, Inc. 2018-09-12
47335-0317-92 3 BOTTLE, DROPPER in 1 BOX (47335-317-92) / 2.5 mL in 1 BOT... XELPROS Sun Pharmaceutical Industries, Inc. 2018-09-12
47335-0317-94 3 BOTTLE, DROPPER in 1 BOX (47335-317-94) / 2.5 mL in 1 BOT... XELPROS Sun Pharmaceutical Industries, Inc. 2018-09-12
47335-0317-98 1 BOTTLE, DROPPER in 1 BOX (47335-317-98) / 2.5 mL in 1 BOT... XELPROS Sun Pharmaceutical Industries, Inc. 2018-09-12
Observed labelers: Sun Pharmaceutical Industries, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.